Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants. | Front Pharmacol;12: 787261, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Biblioteca Virtual en Salud

BVS - Literatura Cientifica y Técnica

Localizar descriptor de asunto Búsqueda Avanzada

Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants.

Glebov, Oleg O.

Glebov OO; Institute of Neuroregeneration and Neurorehabilitation, Qingdao University, Qingdao, China.

Front Pharmacol ; 12: 787261, 2021.

Article en En | MEDLINE | ID: mdl-34975483

Palabras clave

COVID-19; SARS-CoV-2; antidepressants; drug repurposing; endocytosis

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2021 Tipo del documento: Article